203 related articles for article (PubMed ID: 20801081)
1. Glucocorticoid receptor cofactors as therapeutic targets.
Simons SS
Curr Opin Pharmacol; 2010 Dec; 10(6):613-9. PubMed ID: 20801081
[TBL] [Abstract][Full Text] [Related]
2. Modulation of transcription parameters in glucocorticoid receptor-mediated repression.
Sun Y; Tao YG; Kagan BL; He Y; Simons SS
Mol Cell Endocrinol; 2008 Nov; 295(1-2):59-69. PubMed ID: 18583028
[TBL] [Abstract][Full Text] [Related]
3. Equilibrium interactions of corepressors and coactivators with agonist and antagonist complexes of glucocorticoid receptors.
Wang Q; Blackford JA; Song LN; Huang Y; Cho S; Simons SS
Mol Endocrinol; 2004 Jun; 18(6):1376-95. PubMed ID: 15016838
[TBL] [Abstract][Full Text] [Related]
4. Separate regions of glucocorticoid receptor, coactivator TIF2, and comodulator STAMP modify different parameters of glucocorticoid-mediated gene induction.
Awasthi S; Simons SS
Mol Cell Endocrinol; 2012 May; 355(1):121-34. PubMed ID: 22342989
[TBL] [Abstract][Full Text] [Related]
5. Opposing effects of corepressor and coactivators in determining the dose-response curve of agonists, and residual agonist activity of antagonists, for glucocorticoid receptor-regulated gene expression.
Szapary D; Huang Y; Simons SS
Mol Endocrinol; 1999 Dec; 13(12):2108-21. PubMed ID: 10598585
[TBL] [Abstract][Full Text] [Related]
6. Modulation of induction properties of glucocorticoid receptor-agonist and -antagonist complexes by coactivators involves binding to receptors but is independent of ability of coactivators to augment transactivation.
He Y; Szapary D; Simons SS
J Biol Chem; 2002 Dec; 277(51):49256-66. PubMed ID: 12376547
[TBL] [Abstract][Full Text] [Related]
7. Glucocorticoid receptor ligand binding domain is sufficient for the modulation of glucocorticoid induction properties by homologous receptors, coactivator transcription intermediary factor 2, and Ubc9.
Cho S; Kagan BL; Blackford JA; Szapary D; Simons SS
Mol Endocrinol; 2005 Feb; 19(2):290-311. PubMed ID: 15539428
[TBL] [Abstract][Full Text] [Related]
8. Nuclear receptor coregulators differentially modulate induction and glucocorticoid receptor-mediated repression of the corticotropin-releasing hormone gene.
van der Laan S; Lachize SB; Vreugdenhil E; de Kloet ER; Meijer OC
Endocrinology; 2008 Feb; 149(2):725-32. PubMed ID: 18006628
[TBL] [Abstract][Full Text] [Related]
9. Mutations of glucocorticoid receptor differentially affect AF2 domain activity in a steroid-selective manner to alter the potency and efficacy of gene induction and repression.
Tao YG; Xu Y; Xu HE; Simons SS
Biochemistry; 2008 Jul; 47(29):7648-62. PubMed ID: 18578507
[TBL] [Abstract][Full Text] [Related]
10. Ligand binding domain mutations of the glucocorticoid receptor selectively modify the effects with, but not binding of, cofactors.
Lee GS; Simons SS
Biochemistry; 2011 Jan; 50(3):356-66. PubMed ID: 21142156
[TBL] [Abstract][Full Text] [Related]
11. Agonist-specific Protein Interactomes of Glucocorticoid and Androgen Receptor as Revealed by Proximity Mapping.
Lempiäinen JK; Niskanen EA; Vuoti KM; Lampinen RE; Göös H; Varjosalo M; Palvimo JJ
Mol Cell Proteomics; 2017 Aug; 16(8):1462-1474. PubMed ID: 28611094
[TBL] [Abstract][Full Text] [Related]
12. PA1 protein, a new competitive decelerator acting at more than one step to impede glucocorticoid receptor-mediated transactivation.
Zhang Z; Sun Y; Cho YW; Chow CC; Simons SS
J Biol Chem; 2013 Jan; 288(1):42-58. PubMed ID: 23161582
[TBL] [Abstract][Full Text] [Related]
13. Modulation of glucocorticoid receptor induction properties by cofactors in peripheral blood mononuclear cells.
Luo M; Simons SS
Hum Immunol; 2009 Oct; 70(10):785-9. PubMed ID: 19665040
[TBL] [Abstract][Full Text] [Related]
14. Protein-protein interactions and transcriptional antagonism between the subfamily of NGFI-B/Nur77 orphan nuclear receptors and glucocorticoid receptor.
Martens C; Bilodeau S; Maira M; Gauthier Y; Drouin J
Mol Endocrinol; 2005 Apr; 19(4):885-97. PubMed ID: 15591535
[TBL] [Abstract][Full Text] [Related]
15. Receptor interacting protein RIP140 inhibits both positive and negative gene regulation by glucocorticoids.
Subramaniam N; Treuter E; Okret S
J Biol Chem; 1999 Jun; 274(25):18121-7. PubMed ID: 10364267
[TBL] [Abstract][Full Text] [Related]
16. Nuclear receptor coregulators as a new paradigm for therapeutic targeting.
Hsia EY; Goodson ML; Zou JX; Privalsky ML; Chen HW
Adv Drug Deliv Rev; 2010 Oct; 62(13):1227-37. PubMed ID: 20933027
[TBL] [Abstract][Full Text] [Related]
17. Ligand-selective transactivation and transrepression via the glucocorticoid receptor: role of cofactor interaction.
Ronacher K; Hadley K; Avenant C; Stubsrud E; Simons SS; Louw A; Hapgood JP
Mol Cell Endocrinol; 2009 Feb; 299(2):219-31. PubMed ID: 19007848
[TBL] [Abstract][Full Text] [Related]
18. New antiprogestins with partial agonist activity: potential selective progesterone receptor modulators (SPRMs) and probes for receptor- and coregulator-induced changes in progesterone receptor induction properties.
Giannoukos G; Szapary D; Smith CL; Meeker JE; Simons SS
Mol Endocrinol; 2001 Feb; 15(2):255-70. PubMed ID: 11158332
[TBL] [Abstract][Full Text] [Related]
19. Differential modulation of glucocorticoid and progesterone receptor transactivation.
Szapary D; Song LN; He Y; Simons SS
Mol Cell Endocrinol; 2008 Feb; 283(1-2):114-26. PubMed ID: 18215457
[TBL] [Abstract][Full Text] [Related]
20. Evidence for a common step in three different processes for modulating the kinetic properties of glucocorticoid receptor-induced gene transcription.
Chen S; Sarlis NJ; Simons SS
J Biol Chem; 2000 Sep; 275(39):30106-17. PubMed ID: 10899170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
